Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 10-11
Submit an article Journal homepage
104
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients

Kei EndoDivision of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan; Correspondence[email protected]
,
Takayoshi OikawaDivision of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan;
,
Keisuke KakisakaDivision of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan;
,
Akio TamuraDepartment of Radiology, Iwate Medical University School of Medicine, Morioka, Japan
,
Shigeru EharaDepartment of Radiology, Iwate Medical University School of Medicine, Morioka, Japan
&
Yasuhiro TakikawaDivision of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan;
Pages 1340-1346 | Received 17 May 2018, Accepted 17 Jul 2018, Published online: 26 Sep 2018

References

  • Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014.
  • Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2015;61:660–667.
  • Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881–894.
  • Berry K, Taylor J, Liou IW, et al. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:585–593.
  • Hall TC, Garcea G, Metcalfe M, et al. Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study. Hepatogastroenterology. 2013;60:311–317.
  • Luca A, Caruso S, Milazzo M, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 2012;265:124–132.
  • Delgado MG, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012;10:776–783.
  • Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44:448–451.
  • Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13:30–37.
  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550–558.
  • Qi X, Han G, He C, et al. CT features of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol. 2012;36:561–568.
  • Shimada T, Maruyama H, Kondo T, et al. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan. Hepatol Int. 2013;7:1030–1039.
  • Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568–574.
  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
  • DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.
  • Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009; 137:2105–2111.
  • Gulley D, Teal E, Suvannasankha A, et al. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008;53:3012–3017.
  • Qi X, Dai J, Yang M, et al. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Gastroenterol Res Pract. 2015;2015:1.
  • Nagaoki Y, Aikata H, Daijyo K, et al. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatol Res 2018;48:51–58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.